Shopping Cart
Remove All
Your shopping cart is currently empty
Avdoralimab
Copy Product Info
😃Good
Catalog No. T76913Cas No. 2226393-85-5
Alias IPH5401, IPH 5401, Anti-C5aR1 mAb
Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria.
Avdoralimab
Avdoralimab
Copy Product Info😃Good
Catalog No. T76913Alias IPH5401, IPH 5401, Anti-C5aR1 mAbCas No. 2226393-85-5
Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $263 | In Stock | In Stock | |
| 5 mg | $795 | In Stock | In Stock | |
| 10 mg | $1,260 | - | In Stock | |
| 25 mg | $1,870 | - | In Stock | |
| 50 mg | $2,520 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:95.16% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Avdoralimab (IPH 5401) is a humanized monoclonal antibody targeting Complement C5a receptor 1 (C5aR1), used in research on bullous pemphigoid and chronic urticaria. |
| In vitro | Avdoralimab is a whole-human IgG κb monoclonal antibody that targets the complement C5a receptor 1 (C5aR1), preventing it from binding to C5a. Improving the role of complement cascade in tumor biology by reducing the migration and activation of neutrophils and myeloid suppressor cells to the tumor microenvironment, and enhancing the antitumor activity of effector cells such as T cells and natural killer cells. [1] |
| In vivo | Avdoralimab blocked C5A-mediated recruitment and activation of human bone marrow cells and inhibited acute lung injury in human C5aR1 knockin mice. [2] |
| Synonyms | IPH5401, IPH 5401, Anti-C5aR1 mAb |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | Complement C5aR1 |
| Molecular Weight | 145.9 kDa |
| Cas No. | 2226393-85-5 |
| Isotype | Human IgG1 kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Avdoralimab | purchase Avdoralimab | Avdoralimab cost | order Avdoralimab | Avdoralimab in vivo | Avdoralimab in vitro | Avdoralimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.